HEMATOPOIESIS AND SERUM IRON CHANGES FOLLOWING VINCRISTINE SULFATE

[1] BERTINCHAMPS A, 1958, CANCER, V11, P117, DOI 10.1002/1097-0142(195801/02)11:1<117::AID-CNCR2820110122>3.0.CO

[2] 2-2

[3] STUDIES ON ANTIMITOTIC ACTIVITY OF LEUROCRISTINE (VINCRISTINE) [J]. BLOOD, 1963, 21 (01) : 102 - +

[4] CARDINALI GIUSEPPE, 1963, PROC AMER ASSOC CANCER RES, V4, P10

[5] HOST H, 1966, SCAND J HAEMATOL, V3, P193

[6] ISRAELS LG, 1962, CAN J BIOCHEM PHYS, V40, P667

[7] MORPHOLOGIC ABNORMALITIES OF BONE MARROW CELLS INDUCED BY CHEMOTHERAPEUTIC AGENTS DURING TREATMENT OF LEUKEMIA [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1965, 44 (02) : 146 - &

[8] REGULATION OF ERYTHROPOIESIS .18. EFFECT OF VINCRISTINE AND ERYTHROPOIETIN ON BONE MARROW [J]. JOURNAL OF CLINICAL INVESTIGATION, 1966, 45 (08) : 1241 - &

[9] NESBIT M, 1968, P AM ASSOC CANC RES, V9, P54

[10] NEUSS N., 1964, ADVANCE CHEMOTHERAP, V1, P133

[1] BERTINCHAMPS A, 1958, CANCER, V11, P117, DOI 10.1002/1097-0142(195801/02)11:1<117::AID-CNCR2820110122>3.0.CO

[2] 2-2

[3] STUDIES ON ANTIMITOTIC ACTIVITY OF LEUROCRISTINE (VINCRISTINE) [J]. BLOOD, 1963, 21 (01) : 102 - +

[4] CARDINALI GIUSEPPE, 1963, PROC AMER ASSOC CANCER RES, V4, P10

[5] HOST H, 1966, SCAND J HAEMATOL, V3, P193

[6] ISRAELS LG, 1962, CAN J BIOCHEM PHYS, V40, P667

[7] MORPHOLOGIC ABNORMALITIES OF BONE MARROW CELLS INDUCED BY CHEMOTHERAPEUTIC AGENTS DURING TREATMENT OF LEUKEMIA [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1965, 44 (02) : 146 - &

[8] REGULATION OF ERYTHROPOIESIS .18. EFFECT OF VINCRISTINE AND ERYTHROPOIETIN ON BONE MARROW [J]. JOURNAL OF CLINICAL INVESTIGATION, 1966, 45 (08) : 1241 - &

[9] NESBIT M, 1968, P AM ASSOC CANC RES, V9, P54

[10] NEUSS N., 1964, ADVANCE CHEMOTHERAP, V1, P133